Implementation, Efficacy and Costs of Inpatient Equivalent Home-Treatment in German Mental Health Care

NCT04745507 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 629

Last updated 2022-03-16

No results posted yet for this study

Summary

The "inpatient-equivalent home treatment"(IEHT) according to §115d SGB-V is a particular version of the internationally well-known and evidence-based Home Treatment. As a complex intervention, IEHT requires a multi-method evaluation on different levels in the German context. The AKtiV study that is financed by the Innovation Fund of the Federal Joint Committee (proposal ID: VSF2\_2019-108) meets this request. In this quasi-experimental study with a propensity score-matched control group, we assess and combine quantitative and qualitative data. Outcome parameters include classical clinical ones such as hospital readmission rates, mental state, and recovery outcomes. In addition, it evaluates issues concerning the right target population, treatment processes, implementation strategies, and factors associated with positive outcomes. The study takes into account the perspective of patients, relatives, staff as well as decision makers in politics and administration. Therefore, we expect the results to be relevant for a broad audience and to contribute to further refinement and adaption of the model.

Conditions

Interventions

OTHER

Inpatient Equivalent Home Treatment

At-home psychiatric treatment by means of a multiprofessional clinic team (an equivalent to stationary psychiatric care).

Sponsors & Collaborators

  • Medizinische Hochschule Brandenburg Theodor Fontane

    collaborator OTHER
  • Zentrum für Psychiatrie Südwürttemberg

    collaborator UNKNOWN
  • Isar-Amper Klinikum München Ost

    collaborator UNKNOWN
  • Klinik für Psychiatrie und Psychotherapie II der Universität Ulm

    collaborator UNKNOWN
  • Kompetenzzentrum für Klinische Studien, Bremen

    collaborator UNKNOWN
  • Vivantes Klinikum am Urban

    collaborator UNKNOWN
  • Vivantes Netzwerk für Gesundheit GmbH

    lead OTHER

Principal Investigators

  • Sebastian von Peter, Prof. Dr. · Immanuel Klinik Rüdersdorf

  • Andreas Bechdolf, Prof. Dr. · Vivantes Klinikum am Urban

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2022-12-31
Completion
2023-06-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04745507 on ClinicalTrials.gov